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Mapping the distribution of GABAA receptor subtypes represents a promising approach to characterize alterations in cortical
circuitry associated with neurological disorders. We previously reported subtype-selective changes in GABAA receptor expression
in the grey matter of patients with focal epilepsy. In the present follow-up study, we focused on the subcortical white matter in
the same tissue specimens obtained at surgery from 9 patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis,
12 patients with TLE associated with neocortical lesions and 5 patients with frontal lobe epilepsy; post-mortem tissue from
4 subjects served as controls. The subunit composition and distribution of three major GABAA receptor subtypes were deter-
mined immunohistochemically with subunit-specific antibodies. In all cases, a majority of neurons in the white matter was
distinctly labelled, allowing detailed visualization of their dendritic arborization and revealing a differential, cell type-specific
expression pattern of a-subunit variants. In controls, a1-subunit staining was most prominent, displaying a gradient that
decreased with depth, in parallel with the density of NeuN-positive cells. Subsets of pyramidal cells were a3-subunit-positive,
and a2-subunit-labelled neurons were rare. In 19 of the 26 patients with focal epilepsy, no changes were detected as compared
with controls. In five patients with TLE, striking changes in the dendritic arborization of a subset of white matter neurons
were seen with the a1-subunit antibody. In two further patients with TLE, we observed a disorganized dendritic network
immuno-positive for the a1-subunit, cell clusters selectively expressing the a2-subunit and small neuronal aggregates that
expressed all subunits and appeared to connect to neighbouring white matter neurons. All seven patients with anomalies in
the white matter had a selective reduction in a3-containing GABAA receptors in the superficial layers of the grey matter. These
results demonstrate a distinct organization of GABAA receptors in human white matter neurons, consistent with an inhibitory
network that is likely to be integrated functionally with the overlying grey matter. The altered dendritic morphology and changes
in GABAA receptor expression in the white matter of a subset of patients with focal epilepsy are suggestive for a rewiring
of neuronal circuits.
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Introduction
The white matter subjacent to the cerebral cortex in adult human
brain contains considerable numbers of neurons situated among
the fibre tracts (Ramo´n y Cajal, 1900; Kostovic and Rakic, 1980;
Meyer et al., 1992). At present, little is known about the role
of these cells both in normal brain function and in neurological
disease. White matter neurons, also referred to as interstitial
neurons, consist of a heterogeneous population of pyramidal
cells and inhibitory interneurons (Kostovic and Rakic, 1980;
Schiffmann et al., 1988; Meyer et al., 1992; Smiley et al.,
1998). The white matter neurons subjacent to the mammalian
cortex are derived from the embryonic subplate, a transient
structure critical for cortical development (Allendoerfer and
Shatz, 1994; Bystron et al., 2008). In the late pre-natal and
early post-natal period, many of these subplate neurons undergo
programmed cell death, leaving the surviving neurons distributed
throughout the subcortical white matter (Chun and Shatz, 1989;
Kostovic and Rakic, 1990). Recently, Torres-Reveron and
Friedlander (2007) have shown in the mature rodent that these
neurons are functionally connected with the neocortical network.
Similarly, in the human white matter, a possible functional role for
these neurons may be assumed based on their axonal projections
(Mrzljak et al., 1988) and their synaptic inputs (Kostovic and
Rakic, 1980).
The pathological significance of changes in white matter
neurons for human epilepsy remains controversial (Eriksson
et al., 2005b; Kasper, 2005). An increase in the density of these
neurons was reported in patients with primary generalized epilepsy
(Meencke, 1983; Meencke and Janz, 1984), but this finding could
not be confirmed (Opeskin et al., 2000). Excessive numbers of
white matter neurons have been reported in patients with tempo-
ral lobe epilepsy (TLE) although there was overlap between the
epilepsy and the control groups (Hardiman et al., 1988; Emery
et al., 1997; Kasper et al., 1999). In patients with TLE associated
with hippocampal sclerosis (HS), Kasper et al. (2003) reported
increased white matter neuronal density in 5 of 24 cases. Using
design-based stereology in surgical specimens, an increase in the
density of white matter neurons in patients with TLE was observed
in one study (Thom et al., 2001), whereas no significant difference
in number or density was found in another study (Bothwell et al.,
2001). Finally, Thom et al. (2005), in a post-mortem stereological
investigation of patients with poorly controlled seizures, did not
report a significant increase in the density of white matter neurons
in patients with verified HS. Interestingly, a combined histopatho-
logical and PET study in patients with TLE showed a correlation
between an increased number of white matter neurons and
increased white matter binding of 11C-flumazenil, an antagonist
at the benzodiazepine/GABAA receptor complex (Hammers et al.,
2001, 2002). Previous investigations have suggested that GABAA
receptor signalling, which mediates both synaptic and tonic
inhibition (Scimemi et al., 2006), is impaired in the neocortical
grey matter in patients with TLE (Arion et al., 2006; Loup et al.,
2006).
The aim of this study was to examine whether alterations in
the expression of GABAA receptor subunits observed in the hippo-
campus and neocortex of patients with focal epilepsy (Loup et al.,
2000, 2006) also extend to subcortical white matter neurons.
Nineteen GABAA receptor subunits have been identified in the
mammalian CNS (Simon et al., 2004), and these assemble into
pentameric receptors to form distinct subtypes, most of which
include at least one of each of the a, b and g subunit class
(Sieghart and Sperk, 2002; Fritschy and Bru¨nig, 2003). Here, we
utilized an immunohistochemical approach to characterize (i) the
distribution and the density of neurons stained for the neuronal
marker NeuN; and (ii) the neuronal expression of five major
GABAA receptor subunits (a1, a2, a3, b2/3 and g2) in the white
matter of patients with medically refractory focal epilepsy and
controls. The present investigation was based on the same tissue
sections as the earlier study on grey matter, in which we demon-
strated a marked reduction in a3-containing GABAA receptors
exclusively in the superficial neocortical layers in a subset of
patients with TLE (Loup et al., 2006).
Methods
Patient selection
Detailed information on patient selection, intra-operative electrocorti-
graphy and tissue collection has been provided previously (Loup et al.,
2006). Briefly, brain tissue from 26 patients with medically intractable
focal epilepsy was obtained in collaboration with the neurosurgical
units of the University Hospitals of Zurich, Geneva and Strasbourg.
All procedures were undertaken with the informed consent of patients
or their legal next of kin and were approved by the ethics committees
of the respective institutions in accordance with the Declaration
of Helsinki. Based on histopathological findings, in conjunction with
neuroimaging and electro-clinical data, we classified the patients into
groups comprising those with frontal lobe epilepsy (FLE) (n= 5, mean
age at surgery SD: 22.612.3 years, range 5–34 years) and those
with TLE. The latter group was further subdivided into those with HS
(n= 9, mean age at surgery SD: 39.6 14.4 years, range 12–56
years) and those with neocortical lesions (non-HS) (n= 12, mean
age at surgery SD: 28.312.2 years, range 9–49 years). Table 1
provides a summary of relevant clinical data for each patient.
Patients with isolated focal cortical dysplasia, that is, with no other
apparent structural changes, were excluded.
Brain tissue consisting of neocortical grey matter and the underlying
white matter was from resections performed for strictly therapeutic
reasons (Loup et al., 2006). The samples originated from the antero-
lateral temporal neocortex (n= 21), the frontopolar area, the frontal
lateral region and the orbital part of the inferior gyrus of the
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frontal lobe. Control autopsy tissue (mean post-mortem interval SD:
11.2 3.4 h, range 8–16 h) was from four subjects (mean age SD:
62.5 11.1 years, range 48–73 years) with no known history of a
neurological or psychiatric disorder. The left, and, in two cases, also
the right hemispheres were cut into coronal slabs of 1–1.5 cm
thickness. Tissue blocks of the anterolateral temporal neocortex were
dissected that corresponded to the areas removed in those patients
undergoing surgery for epilepsy.
Tissue preparation and
immunohistochemistry
Tissue blocks were rinsed immediately after surgical resection or after
dissection at autopsy in phosphate-buffered saline (PBS) at pH 7.4,
and then immersion-fixed for 6–8 h at 4C under constant agitation
in a mixture of 4% freshly dissolved paraformaldehyde and 15%
saturated picric acid in 0.15 M phosphate buffer at pH 7.4 (Somogyi
and Takagi, 1982) or in 4% paraformaldehyde alone. The fixed tissue
was then pre-treated using a modified antigen-retrieval method based
on microwave irradiation (Loup et al., 1998). Tissue blocks were
cryoprotected in 10, 20 and 30% sucrose in PBS over a period
of 3–4 days, frozen at –28C in isopentane and stored at –80C.
Series of 40 mm-thick sections were subsequently cut in a cryostat
with the plane of section oriented perpendicularly to the pial surface
or the main gyral axis and collected in ice-cold PBS. Each series
of 40mm-thick sections consisted of 18–20 sections. Of these, five
consecutive sections were stained for the five GABAA receptor
subunits and two additional adjacent sections were stained with
antibodies against the neuron-specific nuclear protein NeuN (Wolf
et al., 1996) and for Nissl with cresyl violet. Thus the distance
between the first section of each series of sections was between
720 and 800mm.
The following subunit-specific antibodies were used: mouse
monoclonal antibodies bd-24 and bd-17 recognizing the human
GABAA receptor a1-subunit and both the b2 and b3-subunits,
respectively (Schoch et al., 1985; Ewert et al., 1990), and polyclonal
guinea-pig antisera recognizing the a2, the a3 or the g2-subunit. The
specificity of these antibodies has been demonstrated previously
(Fritschy and Mo¨hler, 1995; Loup et al., 1998; Waldvogel et al.,
1999). The dilutions of the subunit-specific antibodies were:
a1-subunit (monoclonal antibody bd-24), 0.14 mg/ml; a2-subunit
(affinity-purified), 1.3 mg/ml; a3-subunit (crude serum), 1:3000;
b2/3-subunit (monoclonal antibody bd-17), 3.8 mg/ml; and g2-subunit
(crude serum), 1:1500. Further antibodies used were NeuN 1:1000
(MAB377; Chemicon, Temecula, CA, USA), GAD 1:2000 (glutamic
acid decarboxylase GC 3008; BIOMOL, Exeter, UK) and GAT-1
1:3000 (GABA membrane transporter-1; DiaSorin, Stillwater, MN,
USA). Series of free-floating sections were pre-incubated in 1.5%
H2O2 in PBS for 10 min at room temperature to block endogenous
peroxidase activity, washed three times for 10 min in PBS and
processed for immunoperoxidase staining (Hsu et al., 1981) as
described previously (Loup et al., 1998, 2000).
Digital images were obtained with a high-resolution camera
(AxioCam; Zeiss, Jena, Germany) and Zeiss camera software
(AxioVision version 4.5). Images were adjusted for brightness and con-
trast only (Adobe Photoshop version 8.0; Adobe Systems Incorporated,
San Jose´, CA, USA) and not manipulated in any other manner.
Final figures were prepared with Adobe Illustrator (version 10.0;
Adobe Systems Incorporated, San Jose´, CA, USA).
White matter neuron counts
Neurons were counted throughout the white matter using NeuN-
stained sections from controls (temporal lobe; n= 4), FLE (n= 4), HS
(n= 8) and non-HS cases (n= 10). For cell counting, a 12.512.5 mm
ocular grid consisting of 1010 squares and corresponding to an area
of 0.098 mm2 (312.5312.5mm) at 40 objective magnification was
positioned parallel to the grey–white matter border and then moved
vertically downward in stepwise fashion to the lowermost boundary of
the white matter available. In cases where the grey–white matter
border was not readily identifiable, adjacent sections stained for the
a2-subunit were used that revealed the border between Layer VI and
the underlying white matter as an abrupt change in staining intensity.
Serial sections were also examined to ensure that the neurons
observed in the white matter were not part of tangentially cut grey
matter from adjacent cerebral gyri. Two counts per section were
performed in two sections from each specimen. All nuclear profiles
within the grid were counted, except for those crossing the top and
right edges. The vertical extent of the white matter was greatest in
autopsy control tissue, whereas it was variable and dependent on
the type of pathology and operative procedure in the surgical cases.
The results were expressed as mean number of neurons per 0.1 mm2.
In 4 of the 30 cases, the quality of the resected tissue precluded
accurate counts.
White matter neuron counts were analysed for statistical significance
using the Kruskal–Wallis test (non-parametric analysis of variance;
GraphPad Prism, San Diego, CA, USA).
Results
Distribution and density of white
matter neurons in controls and in
patients with focal epilepsy
We first examined the white matter subjacent to temporal
neocortex of control autopsy specimens, which exhibited large
numbers of neurons that were identified with NeuN immuno-
labelling. As described previously using microtubule-associated
protein 2 (MAP2) staining (Meyer et al., 1992; Anderson et al.,
1996) or Nissl staining and the Golgi technique (Kostovic and
Rakic, 1980), the density of labelled neurons was highest in the
white matter immediately below the grey matter and then
decreased with increasing distance from the grey–white matter
border (Figs 1A–C, 2B, E and H). The gradient in neuronal density
was confirmed by counting NeuN-immunoreactive neurons at
fixed intervals, beginning at the grey–white matter border and
continuing to deep within the white matter (Fig. 3A). At higher
magnification, we observed the white matter neurons to be
distributed with a predominantly radial orientation with respect
to the axis of their apical dendrites (Fig. 2B, E and H).
Furthermore, the NeuN-positive somata were generally largest
the closer they were to the grey–white matter border, and
became smaller and more irregularly shaped in the deep white
matter (Fig. 2B, E and H).
Similar numbers of NeuN-immunoreactive neurons were
visualized in the white matter from patients with focal epilepsy.
Furthermore, the gradient in the density of neurons from
2452 | Brain 2009: 132; 2449–2463 F. Loup et al.
superficial to deep white matter was conserved in the three dif-
ferent patient groups: those with FLE, those with HS and those
with non-HS (Fig. 3B–D, respectively). Thus, at each level of
depth, no significant difference was observed in the density of
NeuN-positive neurons between the patient groups and the
control group (P40.05) (Fig. 3). In two of the cases with histo-
pathologically confirmed HS, we did, however, observe striking
changes in the organization of white matter neurons (Figs 7A
and 8F). Thus, NeuN-labelled neurons were irregularly distributed
throughout the white matter and often formed clusters composed
of very few cells surrounded by spaces devoid of neurons
(Fig. 7A). The radial neuronal orientation was largely lost, and
neurons with larger and smaller soma sizes were now intermingled
(Fig. 7A). In addition, small neuronal aggregates were present with
ill-defined borders (Fig. 8F). As there were no cyto-architectural
abnormalities in the overlying grey matter in these two cases with
HS, the changes observed in the white matter were classified as
mild malformation of cortical development Type II (mMCD Type
II) according to Palmini et al. (2004), corroborating the initial
neuropathological diagnosis.
GABAA receptor subtypes in control
white matter neurons
We then determined the distribution of the GABAA receptor sub-
units a1, a2, a3, b2/3 and g2 in the white matter from sections
adjacent to those stained for the neuronal marker NeuN (Figs 1, 2
and 4). For each subunit, we observed similar staining patterns in
the temporal and frontal lobe white matter of all autopsy cases.
As reported for the overlying grey matter of the same specimens
(Loup et al., 2006), the five subunit antibodies revealed distinct
distribution patterns and labelling intensities. Whereas the b2/3
and g2-subunits are included in most GABAA receptor subtypes,
the a-subunit variants represent largely distinct subtypes with a
characteristic pharmacological profile and distribution pattern
(Fritschy and Bru¨nig, 2003). Likewise, in control white matter,
we found a specific and unique distribution for each of the
a-subunit variants, with the a1-subunit being most abundant
(Figs 1D, 2A, D and G). At low power magnification, a1-subunit
staining was highest in the superficial white matter and then
decreased with increasing depth from the grey–white matter
border (Fig. 1D). This pattern of distribution was even more
obvious at higher magnification (Fig. 2A, D and G). Because of
the extensive dendritic network formed by the a1-subunit-labelled
neurons near the border with Layer VI, the individual cell bodies
could not always be identified (Fig. 2A). With increasing depth,
neurons became less numerous, so that the soma and dendrites of
a1-subunit-positive neurons were distinctly outlined (Fig. 2D
and G). The distribution pattern and the density of a1-subunit-
labelled neurons appeared largely similar to those of the
NeuN-stained neurons when comparing adjacent sections (Fig. 2).
The a1-subunit antiserum revealed different types of neurons,
among which the most abundant were pyramidal-like cells with
a long apical dendrite ascending towards the grey matter and with
few basal dendrites (Figs 2D, 4A and B). As shown in Fig. 2D,
the pyramidal cells generally displayed a regular arrangement
with radially aligned apical dendrites. There were also neurons
resembling pyramidal cells, according to their somatodendritic
morphology, but which lacked a main apical dendrite (Fig. 2G).
These neurons were often located in the deep white matter,
millimetres below the grey–white matter border (Fig. 2G). An
additional, prominent cell type was a small, intensely stained
neuron with short, fine dendrites (Figs 2G and 4B). Based on
their strong resemblance to the GAD-positive cells in adjacent
Figure 1 Distribution of neurons and GABAA receptor
a1-subunit immunoreactivity in the white matter subjacent to
temporal neocortex in two control subjects. (A–C) NeuN-
stained sections. (A and B) The density of labelled neurons is
highest in the white matter immediately below Layer VI and
diminishes with increasing distance from the grey–white matter
border. Note that (A) represents a segment of (B) at higher
magnification, with the corresponding vessel marked with
an asterisk. (C and D) Adjacent sections stained for NeuN
(C) and the a1-subunit (D). GABAA receptor a1-subunit
staining parallels the distribution of NeuN-positive white matter
neurons, with greatest intensity in the white matter beneath
Layer VI and diminishing with increasing depth from the grey–
white matter border. All panels in all figures are oriented with
the grey matter on top. Scale bar: (A) 300mm; (B) 1 mm;
(C and D) 500mm.
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sections (Fig. 4C) and their size and dendritic arborization, these
neurons were classified as putative GABAergic interneurons.
A distribution pattern similar to that for the a1-subunit was
found for the a3-subunit, with more neurons labelled close to
the border to Layer VI, and progressively fewer labelled neurons
with increasing depth in the white matter (Fig. 2C, F and I).
Staining for the a3-subunit was, however, less intense, reflecting
the smaller number of neurons labelled. Furthermore, the
a3-subunit antiserum labelled only neurons with pyramidal cell
morphology (Figs 2C, F, I and 4D–F). In contrast, the a2-subunit
antiserum revealed few, and faintly labelled, pyramidal cells that
were mostly located close to the border to Layer VI (Fig. 4G–I).
Typically, these neurons had either a fusiform cell body, with
dendrites that penetrated Layer VI (Fig. 4G and H), or a horizon-
tally oriented cell body with two dendritic trunks parallel to the
grey–white matter border (Fig. 4I). At greater depth, the white
matter was almost devoid of a2-subunit-positive neurons. Finally,
the b2/3 and g2-subunits, which are part of most GABAA receptor
subtypes, exhibited a comparable labelling pattern to that of the
a1-subunit (see Fig. 5A and B). A similar co-distribution of the a1,
b2/3 and g2-subunits was also observed in our previous study
in the grey matter (Loup et al., 2006).
GABAA receptor subtypes in white
matter neurons of patients with focal
epilepsy
The white matter of patients with FLE, HS or non-HS was analysed
for changes in GABAA receptor subunit immunoreactivity. In the
Figure 2 Radial distribution of neurons and differential expression of GABAA receptor subunit immunoreactivity in control white
matter. (A–I) Adjacent sections stained for the a1-subunit (left column, A, D and G), NeuN (middle column, B, E and H) and the
a3-subunit (right column, C, F and I) show that the density of labelled neurons and the intensity of staining are greatest in the white
matter near the border with Layer VI and diminish with increasing depth. (A–C) At 1 mm from the grey–white matter border, numerous
NeuN-immuno-positive neurons are present, many of which exhibit an apical dendrite directed towards Layer VI (B). The extensive
dendritic network formed by the a1-subunit-positive neurons partially occludes many of the labelled somata (A). The staining pattern
for the a3-subunit is similar to that of the a1-subunit, but staining is less intense (C). (D–F) At 3 mm from the grey–white matter
border, neurons are less numerous (E). Immunoreactivity for the a1-subunit outlines the soma and dendrites, revealing a regular
arrangement with radially aligned apical dendrites (D). In comparison, fewer neurons, but also showing a radial distribution, are stained
for the a3-subunit (F). (G–I) At 4 mm from the grey–white matter border, fewer neurons are present (H). Neurons stained for the
a1-subunit (G) are more numerous than neurons stained for the a3-subunit (I). Scale bar: 100 mm.
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patients with a circumscribed lesion in the neocortex (Table 1), the
tissue samples used for study were from the periphery of
the lesion. The results were classified into three main categories.
In the first, which included 19 of 26 patients, the staining pattern
for each of the five subunits appeared unchanged in white matter
neurons when compared with controls. This was the case in the
5 patients with FLE, in 5 of the 9 patients of the HS group and
in 9 of the 12 patients of the non-HS group (Table 1; Fig. 5).
Thus, the gradient in staining intensity from superficial to deep
white matter was maintained in parallel with the gradient in neu-
ronal density (Fig. 3). Furthermore, the radial distribution of the
pyramidal cells with their vertically oriented apical dendrites
was also conserved (Fig. 5A–D). As in control tissue, staining
patterns were largely similar for the a1, b2/3 (Fig. 5A and B)
and g2-subunits (not shown), and staining was more intense for
the a1 than the a3-subunit (Fig. 5C and D). Moreover, at the
cellular level, staining for the three a-subunit variants again
revealed that the a1-subunit was expressed both in pyramidal-
like cells and in putative GABAergic interneurons (Fig. 5E), the
a3-subunit exclusively in pyramidal-like cells (Fig. 5F) and the
a2-subunit in only few pyramidal cells that were mostly located
close to Layer VI (Fig. 5G).
In the second category, comprising five patients, two with HS
and three with non-HS, we observed selective changes in GABAA
receptor a1-subunit staining in white matter neurons (Table 1 and
Fig. 6) without apparent changes in their arrangement and
density, as shown in adjacent sections stained for NeuN (Fig. 3).
Strikingly, neurons expressing the a1-subunit, but not the a2
or a3-subunits, exhibited several long and fine, radiating or pre-
dominantly horizontal dendrites (Fig. 6A–C). Depending on their
orientation in the horizontal plane, it was sometimes possible
to observe processes in cross-section (Fig. 6A and C). These
alterations affected a subset of a1-subunit-positive neurons, as
unchanged pyramidal cells with a radially oriented apical dendrite
were also seen (Fig. 6A and B). Thus, the predominantly horizontal
dendritic trajectories of the morphologically altered neurons
contrasted sharply with the radially arrayed apical dendrites of
normal appearing pyramidal cells, manifesting as a marked
disruption in the radial organization of a1-subunit-positive white
matter neurons (compare Figs 2, 5 and 6).
The third category consisted of two patients with HS and mild
mMCD Type II, in which there were pronounced changes in
GABAA receptor subunit immunoreactivity affecting all subunits
(Figs 7 and 8). In particular, the a1-subunit was prominently
expressed in large numbers of irregularly distributed white
matter neurons, many of which had lost their radial orientation
(Fig. 7B and C). Comparison of adjacent sections labelled for
NeuN and the a1-subunit showed that the distribution pattern
and the density of a1-subunit-labelled neurons closely paralleled
those of NeuN-stained neurons (Fig. 7A and B). As in controls,
a1-subunit immunoreactivity intensely outlined the soma and
dendrites of white matter neurons, but unlike controls, also
revealed a dense and disorganized dendritic network (Figs 7B, C
and 8A). Whereas staining for the a1-subunit was present in both
Figure 3 Neuronal cell counts (mean SD) in 4 controls (A), 4 FLE (B), 8 hippocampal sclerosis (C) and 10 non-HS (D) patients
showing a decreasing gradient in neuronal density as a function of increasing depth in the white matter for all four groups. Sections
stained for the specific neuronal marker NeuN were used. The position of the counting grid relative to the grey–white matter border
is indicated on the x-axis. The value above each bar refers to the number of subjects from whom tissue samples still included
white matter at the depth indicated.
GABA
A
receptors in human white matter neurons Brain 2009: 132; 2449–2463 | 2455
pyramidal-like cells and putative GABAergic interneurons (Fig. 7C),
staining for the a3-subunit was present exclusively in pyramidal-
like cells (Fig. 7D), as noted in control tissue. In addition, most of
the small neuronal clusters identified with NeuN stained intensely
for the a1-subunit (Fig. 7B and C), only faintly for the a3-subunit,
and not at all for the a2-subunit (data not shown). Interestingly,
other cell clusters contained neurons that selectively expressed
the a2-subunit, with intense immunoreactivity that outlined the
soma and numerous, long dendrites (Fig. 7E and F). These
a2-subunit-positive cells tended to appear in linear arrays of two
or three clusters (Fig. 7E). These findings stood in contrast to the
staining pattern in control white matter, where virtually no
neurons were a2-subunit-positive, except for a few located close
to Layer VI (compare Figs 4G–I and 7E and F). Finally, within the
white matter of these two patients we observed small aggregates
of neurons displaying subunit-specific GABAA receptor immuno-
reactivity, which was strong for the a1-subunit (Fig. 8A and C)
and the a2-subunit (Fig. 8B and G), and faint for the a3-subunit
(Fig. 8D). A particularly striking observation was the abundant
dendritic overlap between the neurons located in the aggregates
and those in the neighbouring white matter, as revealed by
a1-subunit staining (Fig. 8C). At higher magnification, these
aggregates, with ill-defined borders, consisted of differentiated
neurons that looked remarkably normal, except that they were
oriented randomly, without any evidence for cortical lamination
(Fig. 8F). The staining pattern of the aggregates was largely similar
to that of the overlying grey matter, as shown for the a2-subunit
(Fig. 8G; see also Loup et al., 2006). Furthermore, we detected
strong GAT-1 immunoreactivity in numerous, randomly oriented
so-called cartridges (Fig. 8E), which represent the axon terminals
of GABAergic chandelier cells that synapse on the axon initial
segment of pyramidal cells (DeFelipe and Gonzalez-Albo, 1998).
A correlation in the expression of
GABAA receptor subtypes between the
grey and the white matter of patients
with focal epilepsy
In a previous publication using the same tissue sections as in the
present study, we reported a selective reduction of a3-containing
GABAA receptors in the superficial layers of the grey matter in a
subset of the 26 patients with focal epilepsy (Loup et al., 2006).
As can be seen in Table 1, of the seven patients in which changes
in GABAA receptor subunit staining were observed in the white
matter, all exhibited concomitant changes in a3-subunit staining
in the overlying grey matter [Fig. 6 in the present study and
Fig. 4D–F in Loup et al. (2006) are from the same patient].
In contrast, in only three of the remaining 19 patients with no
Figure 4 Differential cellular distribution of GABAA receptor subunit immunoreactivity in white matter neurons from control subjects.
(A and B) The a1-subunit is expressed in pyramidal cells and in small and intensely stained putative GABAergic interneurons
(arrowheads). (C) High power magnification of a GAD-stained interneuron. (D–F) The a3-subunit is present in pyramidal-like cells only.
(G–I) The a2-subunit is expressed in very few neurons, near Layer VI, which either have dendrites penetrating Layer VI (G and H)
or horizontally oriented dendritic branches parallel to the grey–white matter border (I). Scale bar: (A, B, D, E, G and H) 50mm;
(C, F and I) 25 mm.
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apparent changes in the white matter was there a decrease in
a3-subunit staining in the overlying grey matter.
Discussion
Three main findings emerge from the presented data. First, in
human white matter we observed a differential and neuron-
specific expression pattern of five major GABAA receptor subunits
(a1, a2, a3, b2/3, g2). Moreover, staining for the a1 and
a3-subunits revealed a decreasing gradient in the density of
neurons from the superficial to the deep white matter, and a
radial distribution of pyramidal cells. Second, in 7 of 26 patients
with focal epilepsy, we detected either selective changes in
a1-subunit labelling, revealing altered dendritic morphology in a
subset of white matter neurons in 5 patients or alterations in all
five subunits in the 2 patients with HS and mMCD Type II. Third,
in these seven patients we observed that the alterations in the
white matter were correlated with decreased a3-subunit staining
in the overlying grey matter. Importantly, as discussed previously
(Loup et al., 2006), it is unlikely that factors such as clinical his-
tory, including drug regimens or staining artefacts biased our
results.
GABAA receptor subtype expression in
the normal human white matter
Immunohistochemical staining for a1, a2, a3, b2/3 and
g2 GABAA receptor subunits permitted an extensive morphological
characterization of white matter neurons. Based on previous
Figure 5 Distribution of GABAA receptor subunit immunoreactivity in white matter neurons from two patients with focal epilepsy.
(A and B) Adjacent sections showing similar staining for the a1-subunit (A) and the b2/3-subunit (B) from a patient with FLE. The
distribution pattern of these subunits is comparable with that seen in controls. (C and D) Adjacent sections stained for the a1 and
a3-subunit from a patient with non-HS. Staining for the a1-subunit (C) is more intense than for the a3-subunit (D) with the overall
pattern for both subunits essentially unchanged in comparison with controls. (E–G) High magnification images of three adjacent
sections from the same patient as in (C) and (D). (E) The a1-subunit is expressed in several pyramidal cells (arrows) and in a small and
intensely stained putative GABAergic interneuron (arrowhead). (F) The a3-subunit is present in pyramidal-like cells only. (G) a2-subunit
staining showing a pyramidal cell with a horizontally oriented soma and dendrites running parallel to the grey–white matter border.
Scale bar: (A and B) 200 mm; (C and D) 100mm; (E–G) 25 mm.
GABA
A
receptors in human white matter neurons Brain 2009: 132; 2449–2463 | 2457
studies indicating that these subunits account for 90% of all
GABAA receptors in rodent brain (Sieghart and Sperk, 2002),
and by comparing NeuN and GABAA receptor subunit immuno-
staining (Figs 1 and 2), we can conclude that we have visualized the
majority of the neurons present in the human white matter.
Furthermore, the dendritic arborization of individual white matter
neurons was revealed in great detail, as we used high affinity anti-
bodies in conjunction with an antigen-retrieval procedure that
enhanced specific immunostaining and reduced non-specific back-
ground (Loup et al., 1998). Based on the size and shape of the soma
and the dendritic pattern, we identified different morphological
types of white matter neurons and determined their topological
organization.
One of our most striking observations was the differential
distribution in white matter neurons of the a1, a2 and
a3-subunits, which form distinct receptor subtypes (Fritschy and
Bru¨nig, 2003). A remarkable cell-type specificity in the expression
of GABAA receptor a-subunit variants was found in the temporal
and frontal lobes from both control and patient tissue samples.
A previous study examining GABAA receptor subunit immuno-
reactivity in the grey matter had reported the presence of a few
a1-subunit-positive neurons at the border between the grey and
the white matter in the human visual cortex (Hendry et al., 1994).
When comparing GABAA receptor subunit architecture and
organization in grey matter (Loup et al., 2006) versus white
matter, both similarities and differences emerge. As in the grey
matter, the most abundantly expressed subunit was a1, which was
present in pyramidal cells and GABAergic interneurons whereas
the a2 and the a3-subunits were present in pyramidal cells only.
Likewise, the GABAA receptor subunits b2/3 and g2, components
of most GABAA receptor subtypes, showed a largely similar stain-
ing pattern to that of the a1-subunit. However, in contrast to the
grey matter where a2-subunit labelling was pronounced, the
underlying white matter in the same tissue sections showed sur-
prisingly few neurons expressing this subunit.
A number of approaches using Nissl staining and the Golgi
technique (Kostovic and Rakic, 1980), MAP2 staining and the
Golgi technique (Meyer et al., 1992), MAP2 staining (Anderson
et al., 1996; Beasley et al., 2002) and NeuN staining (Eastwood
and Harrison, 2003) have shown a gradual decrease in the density
of subcortical white matter neurons with increasing depth in
normal human brain. Our data with a1-subunit-labelled neurons
and NeuN-stained neurons confirm this distribution. Moreover,
depending on the size of the control tissue samples, we were
able to systematically examine the white matter down to a
depth of 8 mm and the cell counts obtained are in the same
range as reported previously in the white matter subjacent to
motor cortex (Meyer et al., 1992). White matter neurons have
also been counted in the temporal, frontal and occipital lobes in
normal human brain (Rojiani et al., 1996), but differences in tissue
processing preclude a meaningful comparison with our results.
Finally, the radial distribution of white matter neurons that we
observed with the a1 and a3-subunits was also noted with
MAP2 staining (Meyer et al., 1992).
Several lines of evidence suggest that the GABAA receptors in
white matter neurons are functional components of GABAergic
circuits. First, the GABAA receptor subunits in the combinations
characteristic for functional receptors were expressed by white
matter neurons (present study). Second, the pre-synaptic
component of the GABAergic synapses, the inhibitory inter-
neurons, are present in white matter, as demonstrated in human
brain on the basis of their morphology (Meyer et al., 1992) or
with antibodies for GABA (Schiffmann et al., 1988), GAD (present
study) or markers for specific classes of GABAergic interneurons
such as neuropeptide Y (Chan-Palay et al., 1985) or calretinin
(Gabbott et al., 1997). Third, symmetrical synaptic junctions
consistent with GABAergic synapses are present in the white
matter of both the developing as well as the adult human and also
monkey telencephalon (Kostovic and Rakic, 1980, 1990). Fourth,
GABA and the GABAA receptor subunits a1 and b2/3 are expressed
in subplate neurons and their subunit-labelled dendrites form sym-
metrical synapses, as reported for developing primate occipital
Figure 6 Disruption in the radial organization of white matter
neurons immunoreactive for the GABAA receptor a1-subunit
in a patient with hippocampal sclerosis. (A–C) Many
a1-subunit-labelled neurons display fine dendrites with an
altered, predominantly horizontal orientation, while other
a1-subunit-labelled neurons exhibit a radially oriented apical
dendrite similar to that seen in control pyramidal cells. The
horizontal dendrites can be followed over long distances, or
are tangentially sectioned, appearing as irregular dots
(arrowheads). Scale bar: (A) 100mm; (B and C) 50 mm.
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cortex (Meinecke and Rakic, 1992). In this respect it is of interest
that white matter neurons have been shown to represent remnants
of subplate neurons (Chun and Shatz, 1989; Kostovic and Rakic,
1990). The implications of their persistence in adult brain and their
role in mature cortical function are, however, only beginning to be
addressed (Torres-Reveron and Friedlander, 2007).
Altered GABAA receptor subtype
expression in the white matter of
patients with focal epilepsy
Previous morphological studies of the white matter from patients
with TLE focused mainly on neuronal cell counts using routine
neuropathological protocols or immunohistochemistry for NeuN
or MAP2 (Hardiman et al., 1988; Emery et al., 1997; Kasper
et al., 1999, 2003; Bothwell et al., 2001; Thom et al., 2001,
2005). Even though the majority of these investigations found
excessive numbers of white matter neurons in patients with TLE
compared with controls, there was considerable overlap between
the two groups. In our study, we observed no increase in the
density of subcortical white matter neurons down to a depth of
8 mm in patients with focal epilepsy. Although we agree that cell
number or density is an important parameter, we believe that the
alterations in neuronal morphology and receptors, as described
here, represent a further indicator that may provide insight
into the underlying pathogenesis of epilepsy. Recently, a new
technique was reported (Eriksson et al., 2005a), which allows
the correlation of quantitative MRI parameters with histopatholo-
gical measures in patients with epilepsy (Eriksson et al., 2007).
GABAA receptor subunit staining in human brain may serve as a
valuable adjunct in this approach.
Interestingly, nuclear imaging studies have shown that patients
with focal epilepsy often exhibit increased white matter binding of
11C-flumazenil, an antagonist at the benzodiazepine/GABAA
receptor complex, notably around the ventricles (Hammers
et al., 2001, 2002, 2003, 2005). In a few of these patients who
had undergone surgery, a correlation was noted between
increased white matter flumazenil binding and increased number
of white matter neurons (Hammers et al., 2001, 2002, 2003). Our
data in two patients suggest a further possibility, namely,
an increase in the number of GABAA receptors expressed by
individual neurons. Although the tissue available to us did not
extend to the periventricular region, GABAA receptor expression
Figure 7 Subunit-specific alterations in GABAA receptor immunoreactivity in the white matter from a patient with hippocampal
sclerosis and mMCD Type II. (A) A NeuN-stained section displaying neurons that are irregularly arranged throughout the white matter,
either standing alone or in small cell clusters (arrows) surrounded by cell-free spaces. The radial neuronal orientation is largely lost.
(B and C) a1-subunit staining reveals many labelled white matter neurons, either standing alone, or within cell clusters (arrowheads).
The radial organization is disrupted and the dendritic network is dense and disorganized. (D) Section adjacent to (C) showing two
a3-subunit-labelled pyramidal-like cells. Note that staining is much less intense for the a3 than the a1-subunit. (E and F) a2-subunit
staining outlines the soma and dendrites of neurons forming the small cell clusters. Scale bar: (A and B) 200mm; (C–E) 100mm;
(F) 50 mm.
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may also be altered at deeper levels of the white matter, as
suggested by these 11C-flumazenil binding studies (Hammers
et al., 2002, 2003, 2005).
In our study, we found no changes in staining for five major
GABAA receptor subunits in 19 of 26 patients across all
three groups with focal epilepsy, that is, FLE, HS and non-HS
(Table 1). We did not examine subunits with less prominent
expression, such as the a4, a5 or d-subunits, which are altered
in rodent models of epilepsy (Fritschy et al., 1999; Houser and
Esclapez, 2003; Peng et al., 2004; Scimemi et al., 2005), as
the corresponding antisera are ineffective in human brain tissue
(a5-subunit, F. Loup and J.M. Fritschy, unpublished data) or, to
our knowledge, not yet available for immunohistochemistry in
human samples. In the other seven patients, all with TLE, we
observed a normal distribution of white matter neurons in five
patients and an irregular distribution of white matter neurons
with microscopic neuronal aggregates corresponding to mMCD
Type II (Palmini et al., 2004) in two patients.
In the five patients with a normal neuronal distribution,
a1-subunit staining revealed aberrant dendritic arborization in a
subpopulation of white matter neurons, a finding that was not
apparent with NeuN staining. Based on their size and morphology,
Figure 8 Subunit-specific GABAA receptor immunoreactivity in neuronal aggregates in the white matter of two patients with
hippocampal sclerosis and mMCD Type II. (A and B) The neuronal aggregates exhibit strong staining for the a1-subunit (A) and
the a2-subunit (B). (C–E) Higher magnification images of a neuronal aggregate. Adjacent sections stained for the a1-subunit (C),
the a3-subunit (D) and GAT-1 (E). Labelling is intense for the a1-subunit (C) and faint for the a3-subunit (D). Note the intricate
a1-subunit-positive dendritic network between the neuronal aggregate and the neighbouring white matter neurons. (E) GAT-1 staining
reveals numerous, randomly oriented so-called cartridges, which represent axon terminals of chandelier cells that form synapses on the
axon initial segment of pyramidal cells. Inset shows a high magnification image of two cartridges (arrowhead). (F and G) Adjacent
sections stained for NeuN (F) and the a2-subunit (G). Aggregates consist of differentiated neurons that are randomly oriented. Intense
a2-subunit labelling is present in the neuropil. The lightly stained round structures represent pyramidal cell somata. Scale bar: (A and B)
1 mm; (C–E) 200mm; inset 15 mm; (F and G) 100mm.
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these neurons appear to be pyramidal cells, but with horizontally
rather than radially oriented dendrites, suggesting a disruption of
neuronal polarization (Crino and Eberwine, 1997). Similar changes
in white matter neurons have been described in patients with focal
epilepsy using Lucifer Yellow microinjections (Belichenko et al.,
1994). As modelling studies predict significant changes in neuronal
firing pattern as a consequence of altered dendritic morphology
(Mainen and Sejnowski, 1996), it is conceivable that abnormal
dendritic orientation could predispose towards aberrant synaptic
connectivity in the white matter.
In the two patients with HS and mMCD Type II, the question
arises as to the origin and the degree of synaptic interaction of the
small aggregates of randomly oriented neurons. With respect
to their morphology and GABAA receptor expression, these
microscopic assemblies of cells may represent heterotopic white
matter neurons, that is, neurons that did not reach their
cortical targets while migrating to the grey matter (Sarnat, 1991;
Mischel et al., 1995). Alternatively, they could be remnants of
subplate neurons that failed to undergo programmed cell
death (Chun and Shatz, 1989). Our findings of small cell clusters
that selectively and strongly expressed the a2-subunit, whereas
control white matter was practically devoid of a2-subunit-positive
cells, are more consistent, however, with defective neuronal
migration.
Heterotopic neurons appear to be integrated functionally with
neurons in neighbouring areas as evidenced in animal models of
cortical malformation (Chevassus-au-Louis and Represa, 1999;
Tschuluun et al., 2005; Ackman et al., 2009), in functional
imaging studies of patients with nodular or band heterotopia
(Richardson et al., 1998; Pinard et al., 2000; Mai et al., 2003;
Tyvaert et al., 2008), and with carbocyanine dye tracing in
patients with nodular heterotopia (Hannan et al., 1999). Our
data also support this view. First, the particularly striking dendritic
overlap between the neurons located in the aggregates and those
in the neighbouring white matter is indicative of functional
interconnectivity. Second, the pyramidal cells in the aggregates
expressed all five GABAA receptor subunits studied here and
GAT-1 staining revealed axon initial segment, which is known to
be targeted by a particular class of GABAergic interneuron, the
chandelier cells (DeFelipe, 1999). As chandelier cells are
parvalbumin-positive, but parvalbumin-immunoreactive cell
bodies are not present in human white matter (Alonso-Nanclares
et al., 2005), it seems likely that the somata of these interneurons
are located in the grey matter.
Further support for a functional circuit encompassing grey and
white matter is provided by the correlation we observed when
comparing the grey matter (Loup et al., 2006) and the white
matter (present study) on the same tissue sections. In all seven
patients where morphological changes and altered GABAA
receptor subunit expression were detected in the white matter,
we found a concomitant reduction in a3-containing GABAA
receptors in the superficial layers of the overlying grey matter.
This pronounced correlation could reflect a pathogenetic process
affecting both grey and white matter during a critical period
of development, or a reaction to a primary insult leading to
subsequent re-organization.
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